In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 5th, 2008 | 37 | Yes |
Popular Name: AZD1152 AZD1152
Find On: PubMed — Wikipedia — Google
CAS Numbers: 722544-51-6 , [722544-51-6]
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.60 | 9.52 | -58.1 | 5 | 10 | 1 | 129 | 508.578 | 13 | ↓ |
Ref Reference (pH 7) | 3.60 | 9.42 | -56.96 | 5 | 10 | 1 | 129 | 508.578 | 13 | ↓ |
Lo Low (pH 4.5-6) | 3.60 | 9.55 | -93.87 | 6 | 10 | 2 | 131 | 509.586 | 13 | ↓ |
Lo Low (pH 4.5-6) | 3.60 | 9.87 | -91.91 | 6 | 10 | 2 | 131 | 509.586 | 13 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Target | Aurora Kinase | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ABL1-1-E | Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.21 | Binding ≤ 10μM |
ANKK1-1-E | Ankyrin Repeat And Protein Kinase Domain-containing Protein 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1500 | 0.22 | Binding ≤ 10μM |
AURKA-1-E | Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic | Eukaryotes | 590 | 0.24 | Binding ≤ 10μM |
AURKB-1-E | Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic | Eukaryotes | 7 | 0.31 | Binding ≤ 10μM |
AURKC-1-E | Serine/threonine-protein Kinase Aurora-C (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4 | 0.32 | Binding ≤ 10μM |
BLK-1-E | Tyrosine-protein Kinase BLK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1500 | 0.22 | Binding ≤ 10μM |
CD11A-1-E | PITSLRE Serine/threonine-protein Kinase CDC2L2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1000 | 0.23 | Binding ≤ 10μM |
CD11B-1-E | PITSLRE Serine/threonine-protein Kinase CDC2L1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.22 | Binding ≤ 10μM |
CDK16-1-E | Serine/threonine-protein Kinase PCTAIRE-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6300 | 0.20 | Binding ≤ 10μM |
CDK7-1-E | Cyclin-dependent Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6200 | 0.20 | Binding ≤ 10μM |
CSF1R-1-E | Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.22 | Binding ≤ 10μM |
CTRO-1-E | Citron Rho-interacting Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5700 | 0.20 | Binding ≤ 10μM |
DDR1-1-E | Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1800 | 0.22 | Binding ≤ 10μM |
EGFR-1-E | Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 980 | 0.23 | Binding ≤ 10μM |
ERBB2-2-E | Receptor Protein-tyrosine Kinase ErbB-2 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 4300 | 0.20 | Binding ≤ 10μM |
FLT3-1-E | Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8 | 0.31 | Binding ≤ 10μM |
HCK-1-E | Tyrosine-protein Kinase HCK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3900 | 0.20 | Binding ≤ 10μM |
KIT-1-E | Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8 | 0.31 | Binding ≤ 10μM |
LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 380 | 0.24 | Binding ≤ 10μM |
LTK-1-E | Leukocyte Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3200 | 0.21 | Binding ≤ 10μM |
LYN-1-E | Tyrosine-protein Kinase Lyn (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.22 | Binding ≤ 10μM |
M4K5-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 160 | 0.26 | Binding ≤ 10μM |
MLTK-1-E | Mixed Lineage Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.22 | Binding ≤ 10μM |
MP2K2-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5700 | 0.20 | Binding ≤ 10μM |
MUSK-1-E | Muscle, Skeletal Receptor Tyrosine Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1500 | 0.22 | Binding ≤ 10μM |
PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 38 | 0.28 | Binding ≤ 10μM |
PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 41 | 0.28 | Binding ≤ 10μM |
PHKG1-1-E | Phosphorylase Kinase Gamma Subunit 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1800 | 0.22 | Binding ≤ 10μM |
PHKG2-1-E | Phosphorylase Kinase Gamma Subunit 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1800 | 0.22 | Binding ≤ 10μM |
PLK4-1-E | Serine/threonine-protein Kinase PLK4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4700 | 0.20 | Binding ≤ 10μM |
RET-1-E | Tyrosine-protein Kinase Receptor RET (cluster #1 Of 1), Eukaryotic | Eukaryotes | 80 | 0.27 | Binding ≤ 10μM |
RIPK2-1-E | Serine/threonine-protein Kinase RIPK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1800 | 0.22 | Binding ≤ 10μM |
SRMS-1-E | Tyrosine-protein Kinase Srms (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7900 | 0.19 | Binding ≤ 10μM |
STK10-1-E | Serine/threonine-protein Kinase 10 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.21 | Binding ≤ 10μM |
STK36-1-E | Serine/threonine-protein Kinase 36 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4600 | 0.20 | Binding ≤ 10μM |
TBA1A-1-E | Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic | Eukaryotes | 470 | 0.24 | Binding ≤ 10μM |
TIE1-1-E | Tyrosine-protein Kinase Receptor Tie-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 350 | 0.24 | Binding ≤ 10μM |
TIE2-1-E | Tyrosine-protein Kinase TIE-2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1900 | 0.22 | Binding ≤ 10μM |
TTK-1-E | Dual Specificity Protein Kinase TTK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 8500 | 0.19 | Binding ≤ 10μM |
UFO-1-E | Tyrosine-protein Kinase Receptor UFO (cluster #1 Of 1), Eukaryotic | Eukaryotes | 390 | 0.24 | Binding ≤ 10μM |
VGFR1-1-E | Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 110 | 0.26 | Binding ≤ 10μM |
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 500 | 0.24 | Binding ≤ 10μM |
YES-1-E | Tyrosine-protein Kinase YES (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3800 | 0.21 | Binding ≤ 10μM |
ZAP70-1-E | Tyrosine-protein Kinase ZAP-70 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8200 | 0.19 | Binding ≤ 10μM |
Z81331-1-O | SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other | Other | 17 | 0.29 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 120 | 0.26 | Binding ≤ 1μM |
M4K5_HUMAN | Q9Y4K4 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5, Human | 160 | 0.26 | Binding ≤ 1μM |
CD11A_HUMAN | Q9UQ88 | PITSLRE Serine/threonine-protein Kinase CDC2L2, Human | 1000 | 0.23 | Binding ≤ 1μM |
PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 38 | 0.28 | Binding ≤ 1μM |
PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 41 | 0.28 | Binding ≤ 1μM |
AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 590 | 0.24 | Binding ≤ 1μM |
AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 1 | 0.34 | Binding ≤ 1μM |
AURKC_HUMAN | Q9UQB9 | Serine/threonine-protein Kinase Aurora-C, Human | 17 | 0.29 | Binding ≤ 1μM |
KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 15 | 0.30 | Binding ≤ 1μM |
TBA1A_RAT | P68370 | Tubulin Alpha-1 Chain, Rat | 470 | 0.24 | Binding ≤ 1μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 170 | 0.26 | Binding ≤ 1μM |
FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 140 | 0.26 | Binding ≤ 1μM |
RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 120 | 0.26 | Binding ≤ 1μM |
TIE1_HUMAN | P35590 | Tyrosine-protein Kinase Receptor Tie-1, Human | 350 | 0.24 | Binding ≤ 1μM |
UFO_HUMAN | P30530 | Tyrosine-protein Kinase Receptor UFO, Human | 390 | 0.24 | Binding ≤ 1μM |
VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 110 | 0.26 | Binding ≤ 1μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 500 | 0.24 | Binding ≤ 1μM |
ANKK1_HUMAN | Q8NFD2 | Ankyrin Repeat And Protein Kinase Domain-containing Protein 1, Human | 1500 | 0.22 | Binding ≤ 10μM |
CTRO_HUMAN | O14578 | Citron Rho-interacting Kinase, Human | 5700 | 0.20 | Binding ≤ 10μM |
CDK7_HUMAN | P50613 | Cyclin-dependent Kinase 7, Human | 6200 | 0.20 | Binding ≤ 10μM |
MP2K2_HUMAN | P36507 | Dual Specificity Mitogen-activated Protein Kinase Kinase 2, Human | 5700 | 0.20 | Binding ≤ 10μM |
TTK_HUMAN | P33981 | Dual Specificity Protein Kinase TTK, Human | 8500 | 0.19 | Binding ≤ 10μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 120 | 0.26 | Binding ≤ 10μM |
DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 1800 | 0.22 | Binding ≤ 10μM |
LTK_HUMAN | P29376 | Leukocyte Tyrosine Kinase Receptor, Human | 3200 | 0.21 | Binding ≤ 10μM |
CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 1400 | 0.22 | Binding ≤ 10μM |
M4K5_HUMAN | Q9Y4K4 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5, Human | 160 | 0.26 | Binding ≤ 10μM |
MLTK_HUMAN | Q9NYL2 | Mixed Lineage Kinase 7, Human | 1700 | 0.22 | Binding ≤ 10μM |
MUSK_HUMAN | O15146 | Muscle, Skeletal Receptor Tyrosine Protein Kinase, Human | 1500 | 0.22 | Binding ≤ 10μM |
PHKG1_HUMAN | Q16816 | Phosphorylase Kinase Gamma Subunit 1, Human | 1800 | 0.22 | Binding ≤ 10μM |
PHKG2_HUMAN | P15735 | Phosphorylase Kinase Gamma Subunit 2, Human | 1800 | 0.22 | Binding ≤ 10μM |
CD11B_HUMAN | P21127 | PITSLRE Serine/threonine-protein Kinase CDC2L1, Human | 1200 | 0.22 | Binding ≤ 10μM |
CD11A_HUMAN | Q9UQ88 | PITSLRE Serine/threonine-protein Kinase CDC2L2, Human | 1000 | 0.23 | Binding ≤ 10μM |
PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 38 | 0.28 | Binding ≤ 10μM |
PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 41 | 0.28 | Binding ≤ 10μM |
ERBB2_HUMAN | P04626 | Receptor Protein-tyrosine Kinase ErbB-2, Human | 4300 | 0.20 | Binding ≤ 10μM |
STK10_HUMAN | O94804 | Serine/threonine-protein Kinase 10, Human | 2800 | 0.21 | Binding ≤ 10μM |
STK36_HUMAN | Q9NRP7 | Serine/threonine-protein Kinase 36, Human | 4600 | 0.20 | Binding ≤ 10μM |
AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 1400 | 0.22 | Binding ≤ 10μM |
AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 1 | 0.34 | Binding ≤ 10μM |
AURKC_HUMAN | Q9UQB9 | Serine/threonine-protein Kinase Aurora-C, Human | 17 | 0.29 | Binding ≤ 10μM |
CDK16_HUMAN | Q00536 | Serine/threonine-protein Kinase PCTAIRE-1, Human | 6300 | 0.20 | Binding ≤ 10μM |
PLK4_HUMAN | O00444 | Serine/threonine-protein Kinase PLK4, Human | 4700 | 0.20 | Binding ≤ 10μM |
RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 1800 | 0.22 | Binding ≤ 10μM |
KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 15 | 0.30 | Binding ≤ 10μM |
TBA1A_RAT | P68370 | Tubulin Alpha-1 Chain, Rat | 470 | 0.24 | Binding ≤ 10μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 2800 | 0.21 | Binding ≤ 10μM |
BLK_HUMAN | P51451 | Tyrosine-protein Kinase BLK, Human | 1500 | 0.22 | Binding ≤ 10μM |
HCK_HUMAN | P08631 | Tyrosine-protein Kinase HCK, Human | 3900 | 0.20 | Binding ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 170 | 0.26 | Binding ≤ 10μM |
LYN_HUMAN | P07948 | Tyrosine-protein Kinase Lyn, Human | 1600 | 0.22 | Binding ≤ 10μM |
FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 140 | 0.26 | Binding ≤ 10μM |
RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 120 | 0.26 | Binding ≤ 10μM |
TIE1_HUMAN | P35590 | Tyrosine-protein Kinase Receptor Tie-1, Human | 350 | 0.24 | Binding ≤ 10μM |
UFO_HUMAN | P30530 | Tyrosine-protein Kinase Receptor UFO, Human | 390 | 0.24 | Binding ≤ 10μM |
SRMS_HUMAN | Q9H3Y6 | Tyrosine-protein Kinase Srms, Human | 7900 | 0.19 | Binding ≤ 10μM |
TIE2_HUMAN | Q02763 | Tyrosine-protein Kinase TIE-2, Human | 1900 | 0.22 | Binding ≤ 10μM |
YES_HUMAN | P07947 | Tyrosine-protein Kinase YES, Human | 3800 | 0.21 | Binding ≤ 10μM |
ZAP70_HUMAN | P43403 | Tyrosine-protein Kinase ZAP-70, Human | 8200 | 0.19 | Binding ≤ 10μM |
VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 110 | 0.26 | Binding ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 1800 | 0.22 | Binding ≤ 10μM |
Z81331 | Z81331 | SW-620 (Colon Adenocarcinoma Cells) | 17 | 0.29 | Functional ≤ 10μM |
Description | Species |
---|---|
activated TAK1 mediates p38 MAPK activation | |
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
CDO in myogenesis | |
Cell surface interactions at the vascular wall | |
Constitutive PI3K/AKT Signaling in Cancer | |
CTLA4 inhibitory signaling | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin D associated events in G1 | |
Cyclin E associated events during G1/S transition | |
DAP12 signaling | |
Downregulation of ERBB2:ERBB3 signaling | |
Downstream signal transduction | |
Downstream TCR signaling | |
Dual incision reaction in GG-NER | |
Dual incision reaction in TC-NER | |
ECM proteoglycans | |
EGFR downregulation | |
EGFR interacts with phospholipase C-gamma | |
EGFR Transactivation by Gastrin | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
ERK2 activation | |
Factors involved in megakaryocyte development and platelet production | |
Fc epsilon receptor (FCERI) signaling | |
FCERI mediated Ca+2 mobilization | |
FCERI mediated MAPK activation | |
FCERI mediated NF-kB activation | |
FCGR activation | |
Formation of HIV elongation complex in the absence of HIV Tat | |
Formation of HIV-1 elongation complex containing HIV-1 Tat | |
Formation of incision complex in GG-NER | |
Formation of RNA Pol II elongation complex | |
Formation of the Early Elongation Complex | |
Formation of the HIV-1 Early Elongation Complex | |
Formation of transcription-coupled NER (TC-NER) repair complex | |
Formation of tubulin folding intermediates by CCT/TriC | |
GAB1 signalosome | |
Gap junction assembly | |
Generation of second messenger molecules | |
Glycogen breakdown (glycogenolysis) | |
GPVI-mediated activation cascade | |
GRB2 events in EGFR signaling | |
GRB2 events in ERBB2 signaling | |
GRB7 events in ERBB2 signaling | |
Growth hormone receptor signaling | |
HIV Transcription Initiation | |
Integrin cell surface interactions | |
Interleukin-1 signaling | |
Interleukin-2 signaling | |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
Kinesins | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MEK activation | |
MHC class II antigen presentation | |
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | |
Mitotic Prometaphase | |
mRNA Capping | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
Neurophilin interactions with VEGF and VEGFR | |
NOD1/2 Signaling Pathway | |
Non-integrin membrane-ECM interactions | |
NoRC negatively regulates rRNA expression | |
p75NTR recruits signalling complexes | |
PD-1 signaling | |
PECAM1 interactions | |
Phosphorylation of CD3 and TCR zeta chains | |
PI3K events in ERBB2 signaling | |
PIP3 activates AKT signaling | |
Platelet Adhesion to exposed collagen | |
PLCG1 events in ERBB2 signaling | |
Post-chaperonin tubulin folding pathway | |
Prefoldin mediated transfer of substrate to CCT/TriC | |
RAF phosphorylates MEK | |
Recruitment of mitotic centrosome proteins and complexes | |
Recruitment of NuMA to mitotic centrosomes | |
Recycling pathway of L1 | |
Regulation of actin dynamics for phagocytic cup formation | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Regulation of signaling by CBL | |
Resolution of Sister Chromatid Cohesion | |
RNA Pol II CTD phosphorylation and interaction with CE | |
RNA Polymerase I Chain Elongation | |
RNA Polymerase I Promoter Escape | |
RNA Polymerase I Transcription Initiation | |
RNA Polymerase I Transcription Termination | |
RNA Polymerase II HIV Promoter Escape | |
RNA Polymerase II Pre-transcription Events | |
RNA Polymerase II Promoter Escape | |
RNA Polymerase II Transcription Elongation | |
RNA Polymerase II Transcription Initiation | |
RNA Polymerase II Transcription Initiation And Promoter Clearance | |
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | |
Role of Abl in Robo-Slit signaling | |
Role of LAT2/NTAL/LAB on calcium mobilization | |
Sema4D induced cell migration and growth-cone collapse | |
Separation of Sister Chromatids | |
SHC1 events in EGFR signaling | |
SHC1 events in ERBB2 signaling | |
Signal transduction by L1 | |
Signaling by constitutively active EGFR | |
Signaling by EGFR | |
Signaling by ERBB2 | |
Signaling by ERBB4 | |
Signaling by FGFR | |
Signaling by PDGF | |
Signaling by SCF-KIT | |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |
Tat-mediated elongation of the HIV-1 transcript | |
Tie2 Signaling | |
Transcription of the HIV genome | |
Translocation of GLUT4 to the plasma membrane | |
Translocation of ZAP-70 to Immunological synapse | |
Uptake and function of anthrax toxins | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation |